Thursday's Small-Cap Winners & Losers
Continental Materials (CUO Quote) fell 2.4% to $28.20 after its second-quarter earnings declined from a year ago.
The company earned $1.19 million, or 74 cents a share, down from $1.43 million and 89 cents a share last year. Sales rose slightly. Inovio Biomedical (INO Quote), a company involved in the development of DNA vaccines, said its partner Tripep AB of Sweden received approvals from the Swedish Medical Products Agency and local ethics committees to initiate a Phase I/II clinical trial of a novel DNA vaccine. The vaccine is designed to treat chronically infected hepatitis C virus patients. Still, its shares dropped nearly 16% to $1.60. Adventrx Pharmaceuticals (ANX Quote), a biopharmaceutical research and development company, rose 3% to $2.32 on word that the Food and Drug Administration has granted the fast track designation for ANX-510, or CoFactor injection. The product is currently being investigated in a Phase III study, with 5-fluorouracil and bevacizumab, for the initial treatment of metastatic colorectal cancer. Winthrop Realty Trust (FUR Quote) was initiated with a hold rating at KeyBanc, but that was good enough for investors, who lifted the real estate investment trust 15.3% to $6.80.- Loading Comments...
- Loading Comments...
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,406.96 | 1,109.30 | 2,197.85 | 33.31 |
Oil *
78.75
|
|
UP
136.49
|
UP
15.82
|
UP
29.97
|
DOWN
0.98
|
10 Yr
3.33%
SPDR Gold
111.63
|
|
+1.33%
|
+1.45%
|
+1.38%
|
-2.86%
|
Data delayed 20 minutes |














